Please upgrade your browser.
"We made a very small nanosensor that can detect cancer-causing molecules or important therapeutic drugs inside of a single living cell," said Michael Strano of Massachusetts Institute of Technology in Cambridge, who worked on the study.
The move is a major victory for campaigners, patients and cancer specialists. They had described Nice's refusal to approve the drugs - which cost up to £70,000 a year per patient - as unfair, inhumane and condemning patients to an unnecessarily early death.
The improvements are due to gains against some leading cancers -- prostate, colorectal, breast and, for men, lung cancer -- but numerous other types still are on the rise, including melanoma and kidney cancer, the report said.
Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
Medarex, Inc. (Nasdaq: MEDX) today announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer. Studies suggest that the PD-1 signaling pathway may play an important role in tumor evasion and escape from host immune responses and may also promote the persistence of certain chronic viral infections.
Biotechnology company Antigenics Inc (AGEN.O: Quote, Profile, Research, Stock Buzz) said on Monday that its Oncophage vaccine extended survival in a small study of patients with brain cancer.
A REVOLUTIONARY painless technique that uses electrical pulses to zap tumours is being trialled at The Alfred hospital to treat cancer.
Scientists have identified three genes linked to the body's processing of fats that may increase the risk of kidney cancer.
Despite what his cancer doctors told him 2 1/2 years ago, Joe Daniels still coaches the Buckeyes' quarterbacks
Learn about renal cancers on the ASCO Cancer.net website
Landmark 15-Year Study Of UCLA Kidney Cancer Patients Shows Aggressive, Personalized Therapy Improves Survival
The one-size-fits-all approach traditionally used in kidney cancer treatment should be changed based on the results of the study.
|Powered by NeonCRM|